Skip to content

VR-ACT After Stroke: a Feasibility Study

VR-ACT After Stroke: a Feasibility RCT of a Virtual Reality Delivery of ACT for Pain Management and Mental Health in Patients With Chronic Post-Stroke Pain

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06990646
Acronym
VR-ACT
Enrollment
30
Registered
2025-05-25
Start date
2025-11-30
Completion date
2026-07-31
Last updated
2025-05-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Pain, Stroke

Keywords

chronic post-stroke pain, contextual-behavioral approaches, virtual reality, acceptance and commitment therapy

Brief summary

This exploratory project aims to develop and pilot test, in a parallel group randomized controlled trial (RCT) design, the feasibility, acceptability, and preliminary efficacy of a self-management virtual reality (VR) 8-week program for pain management and mental health in patients with chronic post-stroke pain (CPSP), in two assessment moments (pre- to post-intervention).

Detailed description

This project has three objectives: O1) to develop and test the feasibility and acceptability of a 8-week VR ACT program (VR-ACT) in a sample of CPSP patients; O2) to pilot test the efficacy of VR-ACT in improving pain, mental health, and adaptive psychological processes and skills, and in reducing the functional connectivity of the Triple Network (DMN, SN, and FPN); O3) To examine the cost-effectiveness of the VR-ACT. The current project will conduct a parallel group design Randomized Controlled Trial (RCT) and will follow a multi-method approach (qualitative and quantitative assessment).

Interventions

BEHAVIORALVR-ACT

8 MODULES OF 3D VIRTUAL REALITY Modules 1 & 2: Awareness Regulation Skills Modules 3, 4 & 5: Acceptance of Pain and Internal Experiences Modules 6, 7 & 8: Behavior Change and Valued Action

BEHAVIORALSham-VR

8 2D non-immersive distracting video-animations delivered through a VR headset.

Sponsors

Unidade Local de Saúde de Coimbra, EPE
CollaboratorOTHER
University of Coimbra
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* medical diagnosis of CPSP; * age between 18 and 80; * implicit de facto internet and computer literacy; * willingness to comply with the study procedures.

Exclusion criteria

* currently with active malignancy; - * severe cognitive impairment; * currently undergoing any psychological intervention or VR-delivered pain management program; * current severe psychiatric symptoms (i.e., psychosis; severe depression; non-suicidal self-injury; suicide attempt in the last month); * language impairment with severe comprehension deficit; * history of photosensitive epilepsy or previous experience of severe simulator sickness; * other neurological conditions (e.g., dementia; Parkinson´s).

Design outcomes

Primary

MeasureTime frameDescription
Pain intensityFrom enrollment to the end of treatment at 8 weeks\- The Numeric Rating Scale (NRS)
Pain ImpactFrom enrollment to the end of treatment at 8 weeks\- Pain Disability Index (PDI)
Mental HealthFrom enrollment to the end of treatment at 8 weeksMental Health: \- Depression Anxiety and Stress Scale (DASS-21)
Psychological and Physical Quality of LifeFrom enrollment to the end of treatment at 8 weeks\- World Health Organization Quality of Life - Bref (WHOQOL- Bref)

Secondary

MeasureTime frameDescription
Mindful AwarenessFrom enrollment to the end of treatment at 8 weeksMindful Awareness: \- Mindful Attention Awareness Scale (MAAS)
Emotional RegulationFrom enrollment to the end of treatment at 8 weeksEmotional Regulation: \- Difficulties in Emotion Regulation Scale - Short Form (DERS-SF)
Psychological FlexibilityFrom enrollment to the end of treatment at 8 weeksPsychological Flexibility: \- Comprehensive Assessment of Acceptance and Commitment Therapy Processes (CompACT)

Contacts

Primary ContactSérgio A Carvalho, PhD
sergiocarvalho@fpce.uc.pt+351 239 851 450

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026